Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 21st World Congress on Radiology & Cancer Research Toronto, Ontario, Canada.

Day 1 :

Conference Series Radiology 2018 International Conference Keynote Speaker Yoshiaki Omura photo
Biography:

Professor Yoshiaki Omura received Oncology Residency Training and a Doctor of Science Degree through research on Pharmaco-Electro Physiology of Single Cells in vivo and in vitro from Columbia University. He published over 250 articles and 7 books. He is currently Editor-in-Chief of Acupuncture and Electro-Therapeutics Research, International Journal of Integrated Medicine, and Executive Editor of Integrative Oncology. Using his new diagnostic method, which received US patent, he can non-invasively and rapidly measure many neurotransmitters, chemicals, asbestos, viruses, and bacteria. He developed a non-invasive, quick diagnostic method of malignancies, as well as a method of evaluating the effects of any treatment. 

Abstract:

Various cancers can be detected non-invasively and rapidly using visible and non-invisible changes appearing at various parts of face (eyebrows, alars of nose, upper and lower lips), etc. Our study indicated that Human papillomavirus-Type 16 (HPV-16) was found in many cancers. We found most of eggs sold in stores have significant HPV-16 infection of egg yolk without infection of egg whites. Strong electromagnetic field exposure of specific part of body from cellular phone is important carcinogenic factor to determine where cancer will develop. Coexistence of multiple cancer-contributing factors can develop cancer in short time of few months. Thus, treatment should include removal of contributing factors. These cancer activities can be inhibited by use of individually determined optimal dose of Vitamin D3. Our study indicated that optimal dose of Vitamin D3 has following 10 unique, beneficial effects: 1) significant Anti-cancer effects without side effects; 2) marked decrease in DNA mutation which is proportional to 8-OH-dG; 3) marked urinary excretion of Viruses, Bacteria, Fungi, and Toxic substances, including Asbestos and toxic metals such as Hg, Pb, and Al; 4) marked increase in Acetylcholine in the brain and the rest of the body; 5) marked increase in DHEA; 6) marked decrease in β-Amyloid (1-42) in brain; 7) marked decrease in Cardiac Troponin I. 8) Marked increase in Thymosin α1 (which has natural, powerful, anti-cancer effects and anti-inflammatory effects); 9) Thymosin β4 (which has significant improvement in circulatory system); 10) anti-allergic effects. Optimal dose of Vitamin D3 was found to increase significant release of Thymosin α1 and Thymosin β4 which are highly beneficial for cancer treatment. Manual stimulation of Thymus gland representation areas exists on the back of the hands at the extension of middle finger, also, release significant amount of Thymosin α1 and Thymosin β4 and contributes significant anti-cancer effects. Among these beneficial effects, particularly anti-cancer effects as well as urinary excretions effects of microorganisms and toxic substances seem to play important role.
 

Keynote Forum

Mohammed Naeem

King Abdullah Specialized Children’s Hospital, Saudi Arabia

Keynote: Critical care management of pediatric oncologic patients: To cure and to care

Time : 11:10-11:50

Conference Series Radiology 2018 International Conference Keynote Speaker Mohammed Naeem  photo
Biography:

Mohammed Naeem MD, FAAP, FCCP has vast interests and experience in care and development of children and adolescents. His passion gears towards constructing and implementing scientific models to improve systems targeting primary, secondary and tertiary care. His ideology takes a positive direction through his in-depth analyses and vision and further to explore multiple ways that would help understand the complex pathological phenomenon and planning to design and implement strategies to overcome these. His particular interest and expertise involves population of children and adolescents requiring intensive care. He had been utilizing his vast experience of research, clinical care, patient safety and strategic planning to ambitiously achieve his goals. Through multiple levels of participation in care and strategic planning relevant to diverse patient population, he had been very successful to make his contributions and judgments being heard and taken in considerations. 

Abstract:

Aim: The scholarly activity shall present critical care aspects for the management of pediatric oncologic patients. Background: Over the last several years, there had been wide advancements in the Radiological diagnosis and overall management of pediatric oncologic patients. This emphasizes the need to have in-depth knowledge communication among various teams involved in the care of the pediatric oncologic patients. In terms of critical management, there are two broad dimensions for pediatric oncologic patients. First, to provide cure of the treatable conditions to pediatric oncologic patients apart from the underlying diagnosis. This includes respiratory failure, cardiac failure, sepsis, renal failure, neurologic critical care, metabolic derangements, post-human stem cell transplant, after toxic treatments, after cardiac arrest. Secondly, to provide care to pediatric oncologic patients if the underlying condition is not curable for example whether the patient needs palliative care or hospice care, what would be a most appropriate setting to manage the patients and other relevant issues. Conclusion: This activity targets to bridge knowledge gaps and to bring various teams involved in the care of pediatric oncologic patients at the same basic awareness. At the end of this activity, the participants shall have wide knowledge about the critical situations encountered in the care of pediatric oncologic patients and to learn the ways to overcome the wide range of situations through available diagnostic modalities, management options, and psychosocial techniques

Conference Series Radiology 2018 International Conference Keynote Speaker Ehab Mohammed  photo
Biography:

Ehab Mohammed has completed his Medical School degree from Cairo University, Egypt, had residency training in Medical and Radiation Oncology, published 36 clinical peer reviewed articles in medical and radiation oncology. Practiced oncology for 20 years in Egypt, ad promoted to a professor of clinical oncology in Cairo University, Egypt 2009. In Canada, Dr Ehab changed his career to Naturopathic Medicine and practcing mainly Oncology Naturopathy for cancer patients. He is a board certified Naturopathic Doctor and practice in Toronto and Grimsby Ontario. 

Abstract:

Background: Advanced hepatocellular carcinoma is one of the most aggressive and poorly controlled malignancies with a limited survival time. Usually, patients with advanced and progressive hepatocellular carcinoma develop deterioration of their liver functions which can be a major cause of their mortality. Case presentation: I am reporting a case of a 71 years old male patient with an advanced hepatocellular carcinoma who had progression after transhepatic chemoembolization and radiation therapy with deterioration of liver function tests then after receiving high dose intravenous vitamin C and subcutaneous Helixor, his liver function returned to normal, and up to the moment of writing this research, he is enjoying a normal liver functions and high physical performance. Conclusion: The use of high dose intravenous vitamin C and Helixor injections can improve the liver functions and overall physical performance in a patient with advanced and progressed hepatocellular carcinoma and deteriorating liver function.
 

Keynote Forum

Zhiwen Zhang

First Affiliated Hospital of Chinese General Hospital, China

Keynote: The effectiveness of stereotactic radiosurgery and bevacizumab for recurrent high-grade gliomas

Time : 12:00-12:40

Conference Series Radiology 2018 International Conference Keynote Speaker Zhiwen Zhang  photo
Biography:

Zhiwen Zhang, MD, PhD, director of Department of Neurosurgery, First Affiliated Hospital of Chinese General Hospital. He has completed his MD and PhD in China, worked in Kyoto University as visiting professor for 4 years. He has published more than 25 papers in reputed journals and has been serving as an editorial board member of repute

Abstract:

Objective: This study aimed to evaluate the efficacy of stereotactic radiosurgery (SRS) combined with bevacizumab (BEV) compared with stereotactic radiosurgery and temozolomide (TMZ) for recurrent high-grade gliomas (HGGs). Methods: Patients with recurrent high-grade glioma who received SRS+BEV (n=35) or SRS+TMZ (n=23) between June 2013 and September 2017 were retrospectively analyzed. All patients were diagnosed with high-grade glioma by operation or biopsy. They received conventional radiotherapy (total about 60Gy) before this treatment. SRS was administered at a median dose of 14Gy, which was followed by BEV administration intravenously at 5mg/Kg with an interval of 1 month. Results: The median overall survival (OS) in the SRS+BEV group was significantly longer than that in the SRS+TMZ group (11.4 vs. 6.2 months; p=0.02). In patients with isocitrate dehydrogenase (IDH) wild-type tumors, the SRS+BEV treatment significantly prolonged survival than the SRS+TMZ treatment (10.7 vs. 5.7 months; p=0.01). One-year survival and two-year survival in the SRS+BEV group were 65.7% and 28.6% respectively, significantly higher than the SRS+TMZ group (51.9% and 18.5%). No severe adverse effect was found. Conclusion: SRS+BEV significantly prolonged survival duration than SRS+TMZ and improve the life quality in patients with recurrent high-grade glioma.
 

  • Cancer Therapy | Cancer Imaging | Nuclear Medicine | Radiology Imaging | Proton Theray Nuclear Medicine | Paediatric Oncology | Computer Assisted Tomography | Ultrasound Imaging | Musculoskeletal

Session Introduction

Mosa Alhamami

University of Toronto, Canada

Title: Manganese-enhanced magnetic resonance imaging of breast cancer cells
Speaker
Biography:

Mosa Alhamami earned his PhD from the University of Toronto for his work on manganese-enhanced MRI of breast cancers. His research was recognized with more than $130,000 of scholarships from local and federal funding sources and was nominated to represent the University of Toronto at the national competition for the Vanier Canada Graduate Scholarship and the provincial competition for the Ontario Women’s Health Scholars Award. Since July 2016, Dr Alhamami has been a Scientific Reviewer for the Journal of Magnetic Resonance Imaging and was recognized by the International Society for Magnetic Resonance in Medicine for his service to the journal.
 

Abstract:

There has been continued interest in engineering MRI contrast agents (CAs) and evaluating their diagnostic efficacy to overcome issues associated with clinically-approved CAs such as Gd-DTPA. Of particular interest are intracellular CAs that can provide sensitive identification of labelled cells, opening the possibility of directly detecting early changes driving cancers at the cellular level before vasculature has been fully formed. To further explore the capabilities of intracellular CAs in T1-weighted MRI of breast cancer, this work aimed at (1) demonstrating the potential of MnCl2-enhanced MRI to detect and characterize early small breast tumors in vivo (2) investigating the potential of manganese-porphyrin-enhanced MRI for sensitive detection of multiple clinical subtypes of breast cancer cells (3) utilizing quantitative MRI to demonstrate the role the balance between hydrophilicity and hydrophobicity plays in developing CAs for effective T1-weighted MRI of cancer. This work has shown that MnCl2, unlike Gd-DTPA, provided enhancement of the entire tumor mass, depicting both tumor borders and interior morphology. At the early stage of tumor growth, MnCl2 also enabled cancer subtype-dependent differential enhancement and characterization. Moreover, this work demonstrated the superior T1 enhancement capabilities of manganese porphyrins over Gd-DTPA of multiple clinical subtypes of breast cancer cells at 3.0T. Also, using quantitative MRI, the more hydrophobic manganese porphyrin, MnTPPS3NH2, is shown to be a more sensitive T1 CA than MnTPPS4 for cellular imaging of breast cancers. Such sensitive cellular detection can potentially lead to lowering the dose needed to achieve positive enhancement and merits further future in vivo investigation

Speaker
Biography:

Carlos Zepeda-Velázquez earned his BSc degree in Pharmaceutical Chemistry from La Salle University and his M.Sc. in Organic Chemistry from National Autonomous University of Mexico in 2003 and 2006 respectively. Subsequently, he worked as a process chemist at Signa, SA de CV (Apotex Pharmachem INC). For his doctoral studies he moved to Canada in 2009 and joined the group of Dr McNulty at McMaster University where he completed the total synthesis of the anticancer natural product (+)-trans-Dihydrolycoricidine. He then moved to the Ontario Institute for Cancer Research under Dr Rima Al-awar, working on novel anti-tumor agents and in 2016 he was promoted to Research Scientist. His research focuses on chemical biology of chromatin regulation and drug discovery.
 

Abstract:

At a fundamental level, gene expression is regulated by epigenetic histone modifications. Histone methyltransferases catalyze the transfer of the methyl group from S adenosylmethionine to specific lysine residues on histones. Mixed lineage leukemia 1 (MLL1) is a methyltransferase that methylates lysine 4 on histone H3 (H3K4me3) and is an important regulator of the haemopoietic system. Dysregulation of MLL1 is often associated with acute myeloid and lymphoid leukemias, making it an attractive therapeutic target. WD40 repeat protein 5 (WDR5) is a component of the multiprotein MLL1 complex that is essential for its methyltransferase activity, and disruption of the WDR5/MLL1 interaction may therefore present a viable therapeutic option for the treatment of MLL-dependent leukemias. Employing structure-based design principles and cheminformatic tools, compounds that bind to WDR5 with low nanomolar affinities were synthesized. Of the various small molecules assessed, OICR-9429 demonstrated the most potent activity with KD values of 51 nM (Biacore), 64 nM (FP) and 52 nM (ITC). OICR9429 also disrupts the interaction of WDR5 with MLL1 and RbBP5 in cells with IC50 values below 1 µM

Speaker
Biography:

Dr Romina Geraldine D’Souza, she had completed my MD Radiology from Father Muller Medical college Mangalore, India, Diplomate of the National Board in Radiology and currently doing a fellowship in Crossectional radiology in Christian Medical College, Vellore India and FRCR 2

Abstract:

Oral cavity malignancies are very highly prevalent in the Indian Subcontinent and in recent times T1 and T2 disease have become the common presentation. Upfront surgery with neck node clearance is the management of choice, however, we aim to prevent the morbidity of nodal clearance if we can prove the absence of nodal disease in the neck preoperatively. We studied 30 patients with oral malignancies who underwent surgery as primary treatment. A total of 127 lymph nodes were identified on MRI and correlated with Histopathology for the presence of metastasis. Our analysis of these nodes showed that using RECIST criteria of short axis >10 mm, has a sensitivity and specificity was 35% and 89% respectively. Thus we studied other imaging parameters that when used in combination would have a better predictive value. STIR proved to be very highly sensitive in detecting the presence of a lymph node while Extracapsular invasion, Rim enhancement, and T2 heterogeneity are highly specific for metastatic involvement. Thus a combination of STIR and any one of the specific findings provides a high Sensitivity and Negative predictive value with a reasonable Specificity which could preclude a neck dissection in c N0 patients. Diffusion studies revealed lower mean ADC in malignant nodes, however, it was not statistically significant to identify metastatic disease in subcentimeter nodes in the neck
 

Mohammed Naeem

King Abdullah Specialized Children’s Hospital, Saudi Arabia

Title: Approach to wide aspects of end of life care in children
Speaker
Biography:

Mohammed Naeem MD, FAAP, FCCP has vast interests and experience in care and development of children and adolescents. His passion gears towards constructing and implementing scientific models to improve systems targeting primary, secondary and tertiary care. His ideology takes a positive direction through his in-depth analyses and vision and further to explore multiple ways that would help understand the complex pathological phenomenon and planning to design and implement strategies to overcome these. His particular interest and expertise involves population of children and adolescents requiring intensive care. He had been utilizing his vast experience of research, clinical care, patient safety and strategic planning to ambitiously achieve his goals. Through multiple levels of participation in care and strategic planning relevant to diverse patient population, he had been very successful to make his contributions and judgments being heard and taken in considerations 

Abstract:

Goal: The aim of this work shop is to prepare pediatric health care workers (HCW) to effectively conceptualize & define concepts of end of life care, identify the child’s clinical status, utilize effective methods of communications and interactions maintain a multidisciplinary approach, ascertain the child and family’s medical and psycho-social needs, execute a formulated plan and take post death steps as an ideal HCW Background: Over the last several years, advancements in medical care of complicated medical conditions like cancers and multi-organ failure syndromes as well as general public awareness of the basic disease processes has placed emphasis on medical community to be more efficient and be prepared to make correct transition from cure to end of life care when appropriate time comes. Overall, there is a gap among HCW’s comprehension, assimilation and swift formulation of line of action regarding realizing the needs of the patients who are approaching end stages of their diseases and as well as of their families. Summary of Learning Objectives: This novel envisioned workshop shall gear the participants to learn and practice the following: 1. Use objective methods to formulate a check list regarding patient’s current medical status 2. Use effective methods of communication to approach patients and their families 3. Identify the medical needs of the patients regarding end of life care 4. Identify medico-legal role of HCW in assistance of post death proceedings
 

Speaker
Biography:

Abstract:

Our research indicated that optimal dose of Vitamin D3 has following 10 unique beneficial effects: 1) significant Anti-cancer effects without side effects, 2) marked decrease in DNA mutation which is proportional to the decrease in 8-OH-dG, 3) marked urinary excretion of Viruses, Bacteria, Fungi, single-cell parasites, & Toxic substances, including Asbestos & metals such as Hg, Pb, & Al, 4) marked increase in Acetylcholine in the brain & the rest of the body, 5) marked increase in DHEA, 6) marked decrease in β-Amyloid (1-42) in brain, 7) marked decrease in Cardiac Troponin I, 8) marked increase in Thymosin α1 (which has natural, powerful, anti-cancer effects & anti-inflammatory effects and enhanced immune system, 9) Thymosin β4 (which has significant improvement in circulatory system), & 10) anti-allergic effects. Although it is well-known that in uterus cancer, ovarian cancer, & breast cancer, Human Papilloma Virus-Type 16 (HPV-16) is involved. We found almost every cancer tissue has HPV-16 infection. In addition, some of the rapidly developed cancer patients, often find mixed co-existing infections of HPV-16, single-cell parasite Toxoplasma Gondii. Our recent research indicated that almost every part of single-cell parasite Toxoplasma Gondii’s cell has a viral infection of Human Herpes Virus-Type 8 (HHV-8). Therefore, most cancer patients have viral infection of HPV-16 with HHV-8. These infections are for some reason about almost same ratio of weight. When the degree of these infections are very high, in presence of other co-existing cancer-promoting factors, cancer can develop very rapidly. Among these important contributing co-existing cancer-promoting factors are repeated exposure of electromagnetic field (EMF), foods & drinks with undesirable contributing factors, harmful underwear, toxic substances or decorations directly touching the skin. Based on the analysis of these problems, we also found most of the eggs from chickens are also infected with HPV-16 & Toxoplasma Gondii with HHV-8. However, these infections only exist at egg yolk and egg white does not have these viral infections. In order to solve these problems, most safe & practical way we develop new method of treating various cancers by the combination of the following 4 methods: 1) Individualized optimal dose of Vitamin D3 using its 10 unique, beneficial effects, 2) Selective drug uptake enhancement method, 3) Manual stimulation of Thymus gland or its representation areas on the back of the hand, & 4) Identification & removal of co-existing major cancer-promoting factors. For example, in the early stage of cancer, when Integrin α5β1 as well as Oncogene CfosAb2 are always increased. In the early stage of cancer when Integrin α5β1 becomes increased about close to 200ng, standard laboratory tests can often confirm presence of cancer using the MRI or other imaging techniques. We use 8-OH-dG to evaluate the aggressiveness of the cancer. Usually, in early stage of cancer, it is 2.5ng. 8-OH-dG is proportional to DNA mutation. DNA mutation is necessary in order for cancer cells to grow. When patient’s condition is advanced & terminal stage, Integrin α5β1 is usually over 1500ng, with metastasis & 8-OHdG becomes 60~80ng or higher. In these patients, when we give individually determined optimal dose of Vitamin D3, for example, Integrin α5β1 of over 1500ng becomes 0.002~0.004ng within 30 minutes after taking individualized optimal dose of Vitamin D3. 8-OH-dG of 60~80ng or higher often reduces to 0.2ng which is within normal range. This significant reduction cannot be compared with many existing standard cancer treatments. Average effective duration of optimal dose of Vitamin D3 is about 8 hours. Therefore, the beneficial effects last average of about 8 hours and you have to take optimal dose every 8 hours. If room temperature is very high, effective time duration reduces to 6~7 hours. If more than 200~300mg of Vitamin C is taken, effect of Vitamin D3 will be completely cancelled. Any food or drink containing large amount of Vitamin C or a fruit with Vitamin C such as lemon juice or orange juice should be avoided. One optimal dose of Vitamin D3 also improves Acetylcholine in the brain & rest of the body. As a result, brain function including memory, concentration, & motor function improves very significantly, particularly for those who have low Acetylcholine levels of 1ng or less. Very strong infection of HPV-16 & HHV-8 markedly reduces from body from over 7000ng to safe range of 500~300ng and large amount of viruses are excreted in urine. Urinary excretion of each virus often increases to 2000~3000ng. Cardiac Troponin I significantly reduces toward normal value due to improvement of cardiovascular circulatory system. In order for optimal dose of Vitamin D3 to reach pathological organ selectively, the author discovered selective drug uptake enhancement method more than 15 years ago by manually stimulating accurate organ representation areas of the hand. In order to make immune system very active, manual stimulation of Thymus gland or its representation areas, particularly at the back of the hand which author discovered in 2017. This makes it the safest treatment without side effects but there are always multiple, major co-existing, cancer-promoting factors. Therefore, our treatment includes identification of major co-existing cancer-contributing factors & removing them. By taking optimal dose of Vitamin D3, both Thymosin α1 & Thymosin β4 increase significantly but additional stimulation of Thymus gland representation area, both Thymosins can reach over 100~150ng from normal value of 5~10ng which enhances both improvements in circulation as well as significantly enhanced immune system